About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CEI Van Outreach Screening Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01510392

CEI Van Outreach Screening Study

The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratocon...

Lead sponsor: Oregon Health and Science University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Oregon Health and Science University

Collaborators

National Eye Institute (NEI)

The identification of many eye diseases would significantly benefit from earlier detection than is available with typical eye exams. Optical coherence tomography (OCT) is an imaging technology that can perform non-contact cross-sectional imaging of tissue structure in real time. It is similar to ultrasound B-mode imaging, except that OCT measures the intensity of reflected light rather than sound waves.

Age

18 - 89 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Participant undergoing a screening examination at the Casey Eye Institute Outreach Van.
•Participants must be between the ages of 18 and 89 years old.

Exclusion Criteria

•Inability to give informed consent.
•Inability to maintain stable fixation for OCT imaging

Related studies

Strategies for Improving Linkage-to-Care After Eye Disease Screening

NCT06943599 · Age Related Macular Degeneration, Diabetic Retinopathy, and more

The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis

NCT07539675 · Primary Angle-Closure Glaucoma

A Trial of Hydrus Microstent Versus Goniotomy

NCT06289491 · Glaucoma, Glaucoma, Open-Angle

Preserflo MicroShunt Versus Trabeculectomy

NCT07496957 · GLAUCOMA 1, OPEN ANGLE, D (Disorder)

Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL

NCT06893965 · Macular Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 12, 2018Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment118

Start dateJan 2012

Last updatedApr 12, 2018

Condition

Glaucoma Macular Disease Keratoconus

Locations shown

Casey Eye Institute Outreach Screening Van

Portland, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions